News

  • Aktiebolaget Segulah acquires shares in Senzime AB

    20 June, 2019

      Aktiebolaget Segulah has entered into an agreement to acquire 650,000 shares in Senzime AB. Senzime develops unique medical devices that enable patients’ biochemical and physiological processes to be monitored before, during, and after surgery. The company’s solutions aim to…

  • Segulah Venture AB acquires shares in Senzime AB

    10 December, 2018

    Segulah Venture AB has entered into an agreement to acquire 2,500,000 shares in Senzime AB, by means of a directed equity issue. Senzime develops unique medical devices that enable patients’ biochemical and physiological processes to be monitored before, during, and…